Heparin Effects (And Mechanisms) In The α2-Antithrombin Inactivation Of Serine Proteases--Thrombin, Plasmin, And Trypsin
It is important to elucidate the effects of heparin on the α2-antithrombin (ATIII) inactivation of serine proteases in order to understand the pharmacological activity of heparin. We have studied the enzyme kinetics of the ATIII inactivation of these proteases, and the effects of heparin on these interactions, using a common amide peptide substrate and protein substrates. We also studied the interactions of heparin with the three proteases.We conclude that the mechanism of the catalytic effect of heparin (observed at 0. 005 unit/ml) toward the thrombin- ATIII reaction is different from the mechanism whereby heparin (only at very high concentration, e.g., 10 unit/ml) can induce an enhanced rate in the plasmin-ATIII reaction. We conclude that the first mechanism involves a heparinthrombin complex, while the mechanism with plasmin involves a heparin-ATIII complex which forms only at high heparin concentrations. This is consistent with known appropriate binding constants. We found that heparin has no effect on the very rapid inactivation of trypsin by ATIII. We further conclude that there is no common mechanism whereby clinically relevant levels of heparin cause general enhanced ATIII-protease reaction rates.We suggest ATIII depletion during heparin therapy might be avoided by using low heparin levels, which would not allow heparin-ATIII complexes to form, yet which would catalyze the thrombin-ATIII reaction. Our finding that ATIII inactivates trypsin at a rate similar to the heparin-catalyzed thrombin-ATIII reaction suggests a physiological role for ATIII in the control of trypsin-like enzymes.